Branched penetratin and penetramax display enhanced intestinal insulin delivery potency compared to their linear counterparts
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.02.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Ragna Guldsmed Diedrichsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biopharmaceuticals and Biobarriers in Drug Delivery (BioDelivery), Department of Pharmacy, Faculty of Health and Medical Sciences, Univers…. Hauptthemen laut MEDLINE: Insulin, Cell-Penetrating Peptides, Carrier Proteins, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Innovative Medicines Initiative, Seventh Framework Programme.
Abstract (Originalsprache)
Oral delivery of biopharmaceuticals can be enhanced by some cell-penetrating peptides applied as carriers. The objective here was to improve the permeability enhancing properties of such two peptides by branching into dimer and trimer variants. The transepithelial permeation of cargos including insulin, dextran, mannitol, and metoprolol mediated by penetratin and its analogue penetramax in their linear and branched versions was evaluated in the Caco-2 cell culture model. The enhancing properties of penetramax and particularly penetratin were significantly increased in accordance with the degree of branching, overall increasing the potency of the molecule. The enhanced cargo permeation was associated with peptide-induced effects on the Caco-2 cell monolayers including immediate and reversible decrease in integrity and alterations of the cell cytoskeleton. Overall, the results of the in vitro studies display that the paracellular pathway is involved in the enhanced cargo permeation and that peptide modification by branching indeed increases the permeation of cargos. In vivo pharmacokinetic and histological assessment with insulin as a cargo confirmed the potential of dimeric penetramax as a carrier in comparison to its linear counterpart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biopharmaceuticals and Biobarriers in Drug Delivery (BioDelivery), Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
- Center for Biopharmaceuticals and Biobarriers in Drug Delivery, Department of Chemistry, Faculty of Science, University of Copenhagen, Thorvaldsensvej 40, 1871 Frederiksberg, Denmark.
- Center for Biopharmaceuticals and Biobarriers in Drug Delivery (BioDelivery), Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark. Ele…
Förderung
- Novo Nordisk Foundation
- Innovative Medicines Initiative
- Seventh Framework Programme
- Københavns Universitet
- European Federation of Pharmaceutical Industries and Associations
Zitieren
APA
Diedrichsen, R. G., Mishra, N. K., Fredholt, F., Heade, J., Sørensen, K. K., Jensen, K. J., & Nielsen, H. M. (2025). Branched penetratin and penetramax display enhanced intestinal insulin delivery potency compared to their linear counterparts. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.044
Vancouver
Diedrichsen RG, Mishra NK, Fredholt F, Heade J, Sørensen KK, Jensen KJ, et al. Branched penetratin and penetramax display enhanced intestinal insulin delivery potency compared to their linear counterparts. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.044
BibTeX
@article{Diedrichsen2025,
author = {Diedrichsen, Ragna Guldsmed and Mishra, Narendra Kumar and Fredholt, Freja and Heade, Joanne and Sørensen, Kasper Kildegaard and Jensen, Knud Jørgen and Nielsen, Hanne Mørck},
title = {Branched penetratin and penetramax display enhanced intestinal insulin delivery potency compared to their linear counterparts},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.02.044}
}
EUVIMED